(Q37969667)

26 August 2017

Interaction of tumor cells and lymphatic vessels in cancer progression (English)

1 reference

26 August 2017

A Alitalo

1

1 reference

26 August 2017

M Detmar

series ordinal

2

1 reference

26 August 2017

language of work or name

English

0 references

publication date

19 December 2011

1 reference

26 August 2017

1 reference

26 August 2017

31

1 reference

26 August 2017

4499-4508

1 reference

26 August 2017

42

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2011.602

26 August 2017

0 references

cites work

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Estimates of cancer incidence and mortality in Europe in 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Ets family members induce lymphangiogenesis through physical and functional interaction with Prox1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

An exquisite cross-control mechanism among endothelial cell fate regulators directs the plasticity and heterogeneity of lymphatic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Tbx1 regulates Vegfr3 and is required for lymphatic vessel development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Lymphatic precollectors contain a novel, specialized subpopulation of podoplanin low, CCL27-expressing lymphatic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Platelets: covert regulators of lymphatic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Podoplanin-Fc reduces lymphatic vessel formation in vitro and in vivo and causes disseminated intravascular coagulation when transgenically expressed in the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Immunological functions of hyaluronan and its receptors in the lymphatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Lymphatic vasculature development: current concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

A role for all-trans-retinoic acid in the early steps of lymphatic vasculature development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphang

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Angiogenic role of LYVE-1-positive macrophages in adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Dynamic, M2-like remodeling phenotypes of CD11c+ adipose tissue macrophages during high-fat diet--induced obesity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

A model for gene therapy of human hereditary lymphedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Cardiovascular failure in mouse embryos deficient in VEGF receptor-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Endothelial cell adhesion to the extracellular matrix induces c-Src-dependent VEGFR-3 phosphorylation without the activation of the receptor intrinsic kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Proteolytic processing of vascular endothelial growth factor-D is essential for its capacity to promote the growth and spread of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Vascular endothelial growth factor-C accelerates diabetic wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Macrophages define dermal lymphatic vessel calibre during development by regulating lymphatic endothelial cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Role of CD11b+ macrophages in intraperitoneal lipopolysaccharide-induced aberrant lymphangiogenesis and lymphatic function in the diaphragm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Notch restricts lymphatic vessel sprouting induced by vascular endothelial growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

VEGFR1 tyrosine kinase signaling promotes lymphangiogenesis as well as angiogenesis indirectly via macrophage recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Structural determinants of vascular endothelial growth factor-D receptor binding and specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Blocking neuropilin-2 function inhibits tumor cell metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

The semaphorins: versatile regulators of tumour progression and tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Hepatocyte growth factor promotes lymphatic vessel formation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Dose-dependent response of FGF-2 for lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Unique patterns of metastases in common and rare types of malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Locoregional spread of cutaneous melanoma: sonography findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

The human cutaneous squamous cell carcinoma microenvironment is characterized by increased lymphatic density and enhanced expression of macrophage-derived VEGF-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Lymphangiogenesis and lymphatic metastasis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Tumor lymphangiogenesis and melanoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Tumor-induced lymphangiogenesis: a target for cancer therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Photodynamic Ablation of Lymphatic Vessels and Intralymphatic Cancer Cells Prevents Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Peritumor lymphatics induced by vascular endothelial growth factor-C exhibit abnormal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Tumor cell transendothelial passage in the absorbing lymphatic vessel of transgenic adenocarcinoma mouse prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Real-time imaging of lymphogenic metastasis in orthotopic human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Illuminating the metastatic process

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Dynamic contrast-enhanced magnetic resonance imaging of tumor-induced lymph flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Quantitative imaging of lymphatic function with liposomal indocyanine green

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Preparing the "soil": the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

From tumor lymphangiogenesis to lymphvascular niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Regional lymph node metastases; a singular manifestation of the process of clinical metastases in cancer: contemporary animal research and clinical reports suggest unifying concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Prognostic impact and therapeutic implications of sentinel lymph node micro-metastases in early-stage breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Micrometastasis of a sentinel lymph node in cutaneous melanoma is a significant prognostic factor for disease-free survival, distant-metastasis-free survival, and overall survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Impact of nodal status and tumor burden in sentinel lymph nodes on the clinical outcomes of cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Prox1 function is required for the development of the murine lymphatic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Lymphatic metastasis in the absence of functional intratumor lymphatics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Letter to the editor: Lymphangiogenesis in primary breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Absence of lymphangiogenesis in ductal breast cancer at the primary tumor site

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Lymphangiogenesis and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

Intestinal and peri-tumoral lymphatic endothelial cells are resistant to radiation-induced apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.602

31 March 2020

Identifiers

DOI

10.1038/ONC.2011.602

1 reference

Dimensions Publication ID

26 August 2017

0 references

1 reference